355 related articles for article (PubMed ID: 15756708)
1. Hematologic aspects of myeloablative therapy and bone marrow transplantation.
Riley RS; Idowu M; Chesney A; Zhao S; McCarty J; Lamb LS; Ben-Ezra JM
J Clin Lab Anal; 2005; 19(2):47-79. PubMed ID: 15756708
[TBL] [Abstract][Full Text] [Related]
2. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in experimental bone marrow transplantation.
Yeager AM
Curr Opin Oncol; 1993 Mar; 5(2):282-9. PubMed ID: 8457615
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.
Dubovsky J; Daxberger H; Fritsch G; Printz D; Peters C; Matthes S; Gadner H; Lion T; Muller-Bérat N
Leukemia; 1999 Dec; 13(12):2059, 2060-9. PubMed ID: 10602430
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
7. Effect of systemic heparan sulfate haploinsufficiency on steady state hematopoiesis and engraftment of hematopoietic stem cells.
Shekels LL; Buelt-Gebhardt M; Gupta P
Blood Cells Mol Dis; 2015 Jun; 55(1):3-9. PubMed ID: 25976459
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
[TBL] [Abstract][Full Text] [Related]
9. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
12. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
Shizuru JA; Jerabek L; Edwards CT; Weissman IL
Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic engraftment and graft failure after bone marrow transplantation.
Quinones RR
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):3-17. PubMed ID: 8095382
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation in children.
Pinkel D
J Pediatr; 1993 Mar; 122(3):331-41. PubMed ID: 8441084
[No Abstract] [Full Text] [Related]
16. A retrospective comparison of allogeneic peripheral blood stem cell versus bone marrow transplantation.
Bittencourt H; Lopes M; de Macedo AV; Teixeira ER; Gomes GG; Ferreira GG; Amaral L; Soares P; Vieira M; Dusse LM
Hematol Oncol Stem Cell Ther; 2009; 2(1):272-7. PubMed ID: 20063557
[TBL] [Abstract][Full Text] [Related]
17. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
[TBL] [Abstract][Full Text] [Related]
18. Sequential renal and bone marrow transplants in a child with Fanconi anemia.
Vincent CL; Primack WA; Hipps J; Kasow KA
Pediatr Transplant; 2016 Feb; 20(1):146-50. PubMed ID: 26481770
[TBL] [Abstract][Full Text] [Related]
19. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(3):144-54. PubMed ID: 10392960
[TBL] [Abstract][Full Text] [Related]
20. Immunohematologic complications of bone marrow transplantation.
Klumpp TR
Bone Marrow Transplant; 1991 Sep; 8(3):159-70. PubMed ID: 1958897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
